CMS proposes paying 340B-acquired drugs at ASP minus 33.4% starting CY 2027, replacing ASP plus 6%, based on survey findings that acquisition costs are well below ASP. Projected 2027 impact includes ...

The rule, released Thursday, builds on Trump administration’s priorities, including cutting Medicare reimbursement for drugs ...

Reducing Medicare payments for 340B drugs is the latest proposal focused on the hotly debated drug discount program.

The Trump administration and Dr. Oz propose major Medicare changes for 2027, focusing on 340B drug payment cuts and ...

A clear look at the 340B program: how hospitals generate revenue from drug discounts, why it has expanded, and the growing ...

The Centers for Medicare and Medicaid Services’ annual outpatient hospital pay increase proposal has come with a potential ...

AbbVie is spearheading a new battle in pharma’s long-running fight to reform the federal government’s 340B drug discount program with a lawsuit that challenges the definition of what it means to be a ...

After years of investigation, the outgoing chairman of the Senate Health, Education, Labor and Pensions Committee has ...

Nonprofit healthcare centers are lobbying for a special exemption from a new Health and Human Services reimbursement review ...

The 340B program helps rural hospitals like Cookeville Regional provide affordable care to vulnerable patients.

Drugmaker Eli Lilly and Co. is restricting access to a drug discount program intended for safety-net hospitals in a move the ...

The 340B Drug Pricing Program was created to help a targeted group of safety net providers care for low-income and uninsured patients. First enacted as part of the Veterans Healthcare Act of 1992, ...